Amy E. Halseth

Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes

Frauke Fehse, Michael Trautmann, Jens J. Holst et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 300 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study

Louis J. Aronne, Ken Fujioka, Vanita R. Aroda et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 178 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity

Steven R. Smith, Louis J. Aronne, Colleen Burns et al. · Diabetes Care · 2008 · 171 citations · Full text

Agriculture, Nutrition, Pharmacotherapy +16

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study

Steven R. Smith, John E. Blundell, Colleen Burns et al. · American Journal of Physiology-Endocrinology and Metabolism · 2007 · 128 citations

Agriculture, Nutritional Sciences, Pharmacology +17

Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo

Amy E. Halseth, Deanna P. Bracy, David H. Wasserman · American Journal of Physiology-Endocrinology and Metabolism · 1999 · 104 citations

Life Sciences, Endocrinology, Physiology +17